Medicus Pharma enters up to $15.35M ATM equity distribution agreement with Maxim and Yorkville

Medicus Pharma Ltd.

ATM program for aggregate offering of up to $15,349,674 of common shares via Maxim Group and Yorkville Securities.
Commission of 3.0% of gross sales; agents also reimbursed for reasonable expenses.
Sales will be at-the-market on Nasdaq Capital Market; no obligation to sell any shares.
Shares to be issued under new S-3 registration statement filed December 29, 2025, pending SEC effectiveness.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Medicus Pharma Ltd. entered into Equity Distribution Agreement with Maxim Group LLC and Yorkville Securities, LLC valued at up to $15,349,674 (effective 2025-12-29).

Action: entry
Agreement: atm program
Counterparty: Maxim Group LLC and Yorkville Securities, LLC
Value: up to $15,349,674
Effective: 2025-12-29

Exact text from the filing

On December 29, 2025, Medicus Pharma Ltd. (the "Company") entered into an Equity Distribution Agreement (the "Agreement") with Maxim Group LLC ("Maxim") and Yorkville Securities, LLC ("Yorkville Securities" and together with Maxim, the "Agents") to create an at-the-market equity program.

View on SEC.gov

201 material agreements filed in the last 30 days. Browse all material agreements →

Medicus Pharma Ltd. filing history →

Source: SEC EDGAR

accession 0001062993-25-017492

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.